Update For Investors With BioChemics
Stoltmann Law Offices continues to investigate BioChemics Inc. Recently, BioChemics’ former founder and CEO, John Masiz, was barred from the securities industry by the Securities and Exchange Commission (SEC) and ordered to pay $120,000. Previously, the Financial Industry Regulatory Authority (FINRA) brought a regulatory action against John Kolinofsky Jr., a supervisor and branch manager of…